tert-Butylhydrazine monohydrochloride → 1-tert-butyl-3-(4-nitrophenyl)-1H-pyrazole
Reaction equation
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([C:10]2[C:14](B3OC(C)(C)C(C)(C)O3)=[CH:13]N(CC(OC(C)(C)C)=O)N=2)=[CH:6][CH:5]=1)([O-:3])=[O:2].Cl.[C:33]([NH:37][NH2:38])([CH3:36])([CH3:35])[CH3:34]>>[CH3:34][C:33]([N:37]1[CH:13]=[CH:14][C:10]([C:7]2[CH:8]=[CH:9][C:4]([N+:1]([O-:3])=[O:2])=[CH:5][CH:6]=2)=[N:38]1)([CH3:36])[CH3:35]Participants
3
Procedure
Following the procedure described for Intermediate 1 with t-butylhydrazine hydrochloride, provided the title compound as the minor isomer. ESMS (M-C(CH3)3+2H): 190.0; HNMR (400 MHz, d6-DMSO) δ 8.20 (d, 2H), 7.86 (d, 2H), 7.7 (d, 1H), 6.55 (d, 1H), 1.25 (s, 9H)
Sources & evidence
- ORD record
- ord-5b6cb64c9e6946b3b3a6c66e82f7b607
- Source dataset
- uspto-grants-2008_09
- Patent number
- US07419988B2
Reaction notes
Loading…